Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease.
about
Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel diseaseTime-course of changes in inflammatory response after whole-body cryotherapy multi exposures following severe exercise.Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy.A subgroup of first-degree relatives of Crohn's disease patients shows a profile of inflammatory markers in the blood which is more typical of Crohn's disease patients than of normal individualsElevated serum values of procollagen III peptide (PIIIP) in patients with ulcerative colitis who will develop pseudopolyps.C-reactive protein levels in the perioperative period as a predictive marker of endoscopic recurrence after ileo-colonic resection for Crohn's disease.C-reactive protein in Crohn's disease: how informative is it?Serum C-reactive protein levels predict neurological outcome after aneurysmal subarachnoid hemorrhage.Systemic and local cytokine production in quiescent ulcerative colitis and its relationship to future relapse: a prospective pilot study.Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease.Cytokines in inflammatory bowel disease.EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imaging.Serum interleukin-6 level is associated with response to infliximab in ulcerative colitis.Saliva Interleukin-6 in patients with inflammatory bowel disease.
P2860
Q24669692-4D75FCED-2129-43F6-8687-70175D6D1893Q33987814-EB7ABEB9-BD80-4628-B261-AFC3499A997DQ34409098-B0413DE9-9933-4A6D-B1D1-38B2F6503E9EQ35070533-FD4C89AF-3C4D-4547-8C89-EC6AAD156218Q36209801-67355A43-1FE9-4B5E-813F-5364191D6266Q37164209-6C0F46AB-8719-4104-8094-0311D9D53641Q38196441-31C333D0-CDD3-4745-B29D-1871D4C24DBAQ40024929-9AEB19A1-1EB4-461B-A167-BC27DD327879Q40421198-D4F1BB82-FB7B-420A-9E36-CF22BB1A60CEQ42840078-53E6FE97-49FD-403B-B692-147B8FE420A0Q43204450-2E4A7132-7E55-448F-B48B-14551AFE43ACQ44512440-7D5FCFAF-FE6F-4496-97C0-7211DD3CA73DQ49682864-2FE540F6-6478-4C09-8F59-F84981A95645Q54511531-4C2293D3-7E91-4099-9C52-F8EDEC0D3212
P2860
Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease.
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Interrelations between interle ...... th inflammatory bowel disease.
@ast
Interrelations between interle ...... th inflammatory bowel disease.
@en
Interrelations between interle ...... th inflammatory bowel disease.
@nl
type
label
Interrelations between interle ...... th inflammatory bowel disease.
@ast
Interrelations between interle ...... th inflammatory bowel disease.
@en
Interrelations between interle ...... th inflammatory bowel disease.
@nl
prefLabel
Interrelations between interle ...... th inflammatory bowel disease.
@ast
Interrelations between interle ...... th inflammatory bowel disease.
@en
Interrelations between interle ...... th inflammatory bowel disease.
@nl
P2860
P356
P1433
P1476
Interrelations between interle ...... th inflammatory bowel disease.
@en
P2093
P2860
P356
10.1136/GUT.35.1.77
P407
P577
1994-01-01T00:00:00Z